Have a look to our brand new video online on EXPERTISES @BIOASTER’s series about SMART OMICS: Video SMART OMICS The BIOASTER omics Hub team presents SMART OMICS concept. Omics technologies...
APPLICATION NOTE from the OMICs HUB about inter-individual heterogeneity in clinical metabolomics studies: Assessment of inter-individual NMR/MS metabolic signatures variability in plasma of a heterogeneous group of healthy volunteers –...
BioFilm Pharma and BIOASTER announced the signature of a research contract to address the challenge of antibiotic resistance. This collaboration will lead to the deciphering of the mode of action...
#OmicsTechnologies are today in the heart of early research in #microbiology and #InfectiousDiseases. To leverage these #technologies in applied research, we need to develop new solutions corresponding to industrial processes...
Kaleido Biosciences to collaborate with BIOASTER and MetaGenoPolis to investigate the health potential of a novel class of therapies targeting the microbiome. Kaleido Biosciences, a U.S.-based clinical-stage healthcare company, and...
A new publication about #Chagas disease has been released on November in Journal of Medicinal Chemistry. Entitled “Chagas Disease Drug Discovery: multiparametric Lead Optimization against Trypanosoma cruzi in AcylAminoBenzothiazole Series”....
Meet us at the first DxPx – Diagnostics Partnering conference in Dusseldorf on November 18th Sara Fröjdö, Partnership Manager at BIOASTER, will be present at the 1st DxPx Diagnostics Partnering...
Don’t forget to register to the next I4ID 2019 congress! Registrations to the 3rd Immunotherapies & Innovation for Infectious Diseases (I4ID2019) are still opened. The congress will be held on...
A new publication has been released this summer in Metabolomics. Entitled “Metabolomics, lipidomics and proteomics profiling of myoblasts infected with Trypanosoma cruzi after treatment with different drugs against Chagas disease”,...
BIOASTER announces a collaboration with Exeliom Biosciences, a leading biotech in the developement of innovative microbiome-based therapies, located in Paris and Dijon, France. The aim of the partnership is to...
7th Annual Single Cell Analysis Congress 07 – 08 November 2019, London, UK Microfluidics BIOASTER will be attending the 7th Annual Single Cell Analysis Congress 07 – 08 November 2019,...
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
